166 Results for "

2C9

" in MedChemExpress (MCE) Product Catalog:
Products (166)

166 Results for "2C9" in MCE Product Catalog:

Cat. No.: HY-U00048
CAS No.: 841-73-6
Synonyms: Paramidin; Paramidine
Target:  

Cytochrome P450

Research Areas:  

Inflammation/Immunology

Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent.
loading...
    loading...
Cat. No.: HY-N1201S
CAS No.: 263711-74-6
Apigenin-d5 is a deuterated labeled Apigenin . Apigenin (4',5,7-Trihydroxyflavone) is a competitive CYP2C9 inhibitor with a Ki of 2 μM.
loading...
    loading...
Cat. No.: HY-N0893R
CAS No.: 36062-04-1
Synonyms: HZIV 81-2 (Standard)
Tetrahydrocurcumin (Standard) is the analytical standard of Tetrahydrocurcumin. This product is intended for research and analytical applications. Tetrahydrocurcumin is a Curcuminoid found in turmeric (Curcuma longa) that is produced by the reduction of Curcumin. Tetrahydrocurcumin inhibit CYP2C9 and CYP3A4.
loading...
    loading...
Cat. No.: HY-B0258S
CAS No.: 1184986-45-5
Synonyms: CI-719-d6
Gemfibrozil-d6 is the deuterium labeled Gemfibrozil. Gemfibrozil is an activator of PPAR-α, used as a lipid-lowering agent; Gemfibrozil is also a nonselective inhibitor of several P450 isoforms, with Ki values for CYP2C9, 2C19, 2C8, and 1A2 of 5.8, 24, 69, and 82 μM, respectively.
loading...
    loading...
Cat. No.: HY-B0258R
CAS No.: 25812-30-0
Synonyms: CI-719 (Standard)
Gemfibrozil (Standard) is the analytical standard of Gemfibrozil. This product is intended for research and analytical applications. Gemfibrozil is an activator of PPAR-α, used as a lipid-lowering agent; Gemfibrozil is also a nonselective inhibitor of several P450 isoforms, with Ki values for CYP2C9, 2C19, 2C8, and 1A2 of 5.8, 24, 69, and 82 μM, respectively.
loading...
    loading...
Cat. No.: HY-114415
CAS No.: 2239272-16-1
Purity:  98.39%
Target:  

Parasite

Research Areas:  

Infection

AWZ1066S is a highly potent, specific and orally active anti-Wolbachia agent with EC50 value of 121 nM. AWZ1066S also is a weak CYP2C9 inhibitor and a weak CYP3A4 inducer with IC50 values of 9.7 μM and 37 uM, respectively. AWZ1066S can be used for the research of tropical diseases such as Onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) .
loading...
    loading...
Cat. No.: HY-105408A
CAS No.: 221246-12-4
Fandosentan potassium is a potent endothelin A receptor (ETAR) antagonist. Fandosentan potassium inhibits CYP2C9 and CYP3A4 activities with IC50 values of 39.6 and 21.6 μM, respectively. Fandosentan potassium reverses the hypoxic pulmonary vasoconstriction in the perinatal lamb. Fandosentan potassium can be used for pulmonary hypertension research [1][2].
loading...
    loading...
Cat. No.: HY-131495
CAS No.: 52079-10-4
Purity:  95.73%
Synonyms: (S)-6-Desmethyl Naproxen
Target:  

COX

Research Areas:  

Inflammation/Immunology

(S)-6-O-Desmethylnaproxen ((S)-6-Desmethyl Naproxen) is a metabolite of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (+)-naproxen ((S)-naproxen). (S)-6-O-Desmethylnaproxen is formed from (S)-naproxen by the cytochrome P450 (CYP) isoforms CYP1A2 and CYP2C9.
loading...
    loading...
Cat. No.: HY-13463BS
Synonyms: AKR-501-d8 hydrochloride; E5501-d8 hydrochloride; YM477-d8 hydrochloride
Avatrombopag-d8 (hydrochloride) is deuterium labeled Avatrombopag (hydrochloride). Avatrombopag (AKR-501) hydrochloride is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag hydrochloride mimics the biological activities of TPO. Avatrombopag hydrochloride increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag hydrochloride is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A .
loading...
    loading...
Cat. No.: HY-13463R
CAS No.: 570406-98-3
Synonyms: AKR-501 (Standard); E5501 (Standard); YM477 (Standard)
Avatrombopag (Standard) is the analytical standard of Avatrombopag. This product is intended for research and analytical applications. Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A .
loading...
    loading...
Cat. No.: HY-B1218R
CAS No.: 526-08-9
Sulfaphenazole (Standard) is the analytical standard of Sulfaphenazole. This product is intended for research and analytical applications. Sulfaphenazole is a selective inhibitor of human cytochrome P450 (CYP) 2C9 enzyme. Sulfaphenazole is a cytoprotective agent against light-induced death of photoreceptors. Sulfaphenazole inhibits light-induced necrosis and mitochondrial stress-initiated apoptosis. Sulfaphenazole is an off patent sulfonamide antibiotic and demonstrates bactericidal activity through enhanced M1 macrophage activity. Sulfaphenazole can significantly reduce infarct size and restore post-ischemic coronary flow following ischemia and reperfusion .
loading...
    loading...
Cat. No.: HY-151251
CAS No.: 3010895-55-0
Research Areas:  

Infection

CYP2C9/CYP2C19-IN-1 (compound 22d) is a potent CYP2C9/CYP2C19 inhibitor, possessing no hepatotoxicity and ames toxicity. CYP2C9/CYP2C19-IN-1 can be used in study of anti-ZIKV .
loading...
    loading...
Cat. No.: HY-153371
CAS No.: 1853203-01-6
Target:  

Liposome

Research Areas:  

Others

50-C2-C9-4tail has been used in the generation of lipid nanoparticles (LNPs) for the delivery of siRNA and mRNA in vitro and in vivo.
loading...
    loading...
Cat. No.: HY-167872
CAS No.: 108210-73-7
Target:  

Cytochrome P450

Research Areas:  

Others

Bifeprofen, a cytochrome P450 2C9 (CYP2C9) inhibitor, exhibits dose-dependent inhibition (75 μM, 50%) .
loading...
    loading...
Cat. No.: HY-116601
CAS No.: 17834-02-5
Target:  

Cytochrome P450

Research Areas:  

Others

6-Hydroxywarfarin is a metabolite of (+) -warfarin. 6-Hydroxywarfarin is a weaker vitamin K antagonist. 6-Hydroxywarfarin is metabolized by the cytochrome P450 isomer 2C9 (CYP2C9) .
loading...
    loading...
Cat. No.: HY-15550S1
CAS No.: 1189656-64-1
4'-Hydroxy diclofenac- 13C6 is the 13C labeled 4'-Hydroxy diclofenac . 4'-Hydroxy diclofenac is an orally active metabolite of Diclofenac (HY-15036) by cytochrome P450 2C9 (CYP2C9). 4'-Hydroxy diclofenac has anti-inflammatory and analgesic properties .
loading...
    loading...
Cat. No.: HY-Z2667
CAS No.: 119141-89-8
Synonyms: (R)-Omeprazole; (+)-Omeprazole
(R)-Esomeprazole ((R)-Omeprazole; (+)-Omeprazole) is an orally active cytochrome P450 2C19, CYP3A4, and CYP2C9-related metabolic modulator. (R)-Esomeprazole can be used in studies of digestive system diseases and compound metabolic interactions .
loading...
    loading...
Cat. No.: HY-N1201S1
Apigenin- 13C is the 13C-abeled Apigenin (HY-N1201). Apigenin is a competitive CYP2C9 inhibitor with a Ki of 2 μM .
loading...
    loading...
Cat. No.: HY-177070
CAS No.: 2640653-91-2
Target:  

Xanthine Oxidase

Research Areas:  

Inflammation/Immunology

Angexostat (Compound 2) is an inhibitor of xanthine oxidase. Angexostat exhibits high permeability. Angexostat inhibits CYP2C9 with an IC50 of 18.1 μM. Angexostat can be studied in research for xanthine oxidase-related diseases such as hyperuricemia and gout .
loading...
    loading...
Cat. No.: HY-132399S
CAS No.: 1189980-63-9
Methsuximide-d5 is the deuterated-labeled Methsuximide (HY-B1376). Methsuximide (Mesuximide) is an orally active succinimide-derived antiepileptic agent. Methsuximide interacts with cytochrome P-450, increases the level of hepatic microsomal cytochrome P-450, and inhibits or competes with the cytochrome P-450 CYP 2C9/10 subtype. Methsuximide can be used in epilepsy-related research .
loading...
    loading...